MX2012012938A - Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. - Google Patents

Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.

Info

Publication number
MX2012012938A
MX2012012938A MX2012012938A MX2012012938A MX2012012938A MX 2012012938 A MX2012012938 A MX 2012012938A MX 2012012938 A MX2012012938 A MX 2012012938A MX 2012012938 A MX2012012938 A MX 2012012938A MX 2012012938 A MX2012012938 A MX 2012012938A
Authority
MX
Mexico
Prior art keywords
group
optionally substituted
aromatic
heteroaromatic
process according
Prior art date
Application number
MX2012012938A
Other languages
English (en)
Spanish (es)
Inventor
Jean-Pierre Lecouve
Lucile Vaysse-Ludot
Jean-Luc Renaud
Nicolas Pannetier
Solenne Moulin
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47115640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012012938(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2012012938A publication Critical patent/MX2012012938A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2235/00—Indexing scheme associated with group B01J35/00, related to the analysis techniques used to determine the catalysts form or properties
    • B01J2235/05—Nuclear magnetic resonance [NMR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2012012938A 2011-12-20 2012-11-07 Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. MX2012012938A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1103933A FR2984319B1 (fr) 2011-12-20 2011-12-20 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
MX2012012938A true MX2012012938A (es) 2013-06-19

Family

ID=47115640

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012938A MX2012012938A (es) 2011-12-20 2012-11-07 Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.

Country Status (34)

Country Link
US (1) US8513410B2 (enExample)
EP (1) EP2607353B1 (enExample)
JP (1) JP5670406B2 (enExample)
KR (1) KR101470879B1 (enExample)
CN (1) CN103172566B (enExample)
AR (1) AR088678A1 (enExample)
AU (1) AU2012244188B2 (enExample)
BR (1) BR102012028614A2 (enExample)
CA (1) CA2795741C (enExample)
CL (1) CL2012003136A1 (enExample)
CY (1) CY1115682T1 (enExample)
DK (1) DK2607353T3 (enExample)
EA (1) EA026510B1 (enExample)
ES (1) ES2525032T3 (enExample)
FR (1) FR2984319B1 (enExample)
GE (1) GEP20156350B (enExample)
HR (1) HRP20141023T1 (enExample)
JO (1) JO3031B1 (enExample)
MA (1) MA34276B1 (enExample)
MD (1) MD4336C1 (enExample)
MX (1) MX2012012938A (enExample)
MY (1) MY170662A (enExample)
PE (1) PE20131097A1 (enExample)
PL (1) PL2607353T3 (enExample)
PT (1) PT2607353E (enExample)
RS (1) RS53541B1 (enExample)
SA (1) SA112330994B1 (enExample)
SG (1) SG191471A1 (enExample)
SI (1) SI2607353T1 (enExample)
TW (1) TWI440627B (enExample)
UA (1) UA111329C2 (enExample)
UY (1) UY34423A (enExample)
WO (1) WO2013093220A1 (enExample)
ZA (1) ZA201208160B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN105669554A (zh) * 2016-02-22 2016-06-15 徐建立 一种盐酸伊伐布雷定杂质及其制备方法和应用
FR3071833B1 (fr) * 2017-09-29 2020-01-03 Universite Paris-Sud Nouveau procede de synthese d'amines tertiaires dissymetriques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US6225487B1 (en) * 1998-04-17 2001-05-01 Symyx Technologies, Inc. Ancillary ligands and metal complexes, catalysts and compositions using same and methods of testing
US6521793B1 (en) * 1998-10-08 2003-02-18 Symyx Technologies, Inc. Catalyst ligands, catalytic metal complexes and processes using same
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP1595888A1 (en) * 2004-05-11 2005-11-16 Degussa AG Cycloolefin phosphine ligands and their use in catalysis
EP2460797A3 (en) * 2006-11-30 2012-12-05 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
EP2471780B1 (en) * 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
US7857994B2 (en) 2007-05-30 2010-12-28 GE Lighting Solutions, LLC Green emitting phosphors and blends thereof
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
MY170662A (en) 2019-08-26
ZA201208160B (en) 2013-06-26
WO2013093220A1 (fr) 2013-06-27
CY1115682T1 (el) 2017-01-25
CN103172566A (zh) 2013-06-26
EP2607353A1 (fr) 2013-06-26
US20130158256A1 (en) 2013-06-20
US8513410B2 (en) 2013-08-20
GEP20156350B (en) 2015-08-25
NZ603483A (en) 2014-02-28
MD4336C1 (ro) 2015-10-31
EA201201385A1 (ru) 2013-06-28
CL2012003136A1 (es) 2014-08-01
RS53541B1 (sr) 2015-02-27
JP5670406B2 (ja) 2015-02-18
BR102012028614A2 (pt) 2014-12-16
KR20130071350A (ko) 2013-06-28
MA34276B1 (fr) 2013-06-01
FR2984319A1 (fr) 2013-06-21
HK1186733A1 (zh) 2014-03-21
UY34423A (es) 2013-07-31
FR2984319B1 (fr) 2013-12-27
UA111329C2 (uk) 2016-04-25
JP2013129650A (ja) 2013-07-04
CA2795741C (fr) 2015-09-08
JO3031B1 (ar) 2016-09-05
AU2012244188B2 (en) 2015-07-30
SA112330994B1 (ar) 2015-08-03
PL2607353T3 (pl) 2015-01-30
AR088678A1 (es) 2014-06-25
TWI440627B (zh) 2014-06-11
DK2607353T3 (en) 2014-12-08
MD4336B1 (ro) 2015-03-31
PT2607353E (pt) 2014-10-10
AU2012244188A1 (en) 2013-07-04
ES2525032T3 (es) 2014-12-16
SG191471A1 (en) 2013-07-31
CN103172566B (zh) 2015-11-18
EA026510B1 (ru) 2017-04-28
KR101470879B1 (ko) 2014-12-09
EP2607353B1 (fr) 2014-08-27
TW201326132A (zh) 2013-07-01
SI2607353T1 (sl) 2014-12-31
CA2795741A1 (fr) 2013-06-20
PE20131097A1 (es) 2013-10-12
HRP20141023T1 (hr) 2014-12-05

Similar Documents

Publication Publication Date Title
Fuchs et al. Tandem rhodium‐catalyzed hydroformylation–hydrogenation of alkenes by employing a cooperative ligand system
US8835691B2 (en) Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
Wang et al. Easy access to enamides: a mild nickel-catalysed alkene isomerization of allylamides
KR101243408B1 (ko) 루테늄 화합물 및 광학 활성 아미노알코올 화합물의 제조 방법
MX2012012938A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
CN101775035A (zh) 一类氨基酸型两性水溶性手性膦配体的合成及其在不对称催化氢化中的应用
Wu et al. A highly efficient catalyst FeCl3 in the synthesis of α‐amino phosphonates via three‐component reactions
Quirmbach et al. Synthesis of heterofunctionalized multidentate diphosphines
Biricik et al. New bis (diphenylphosphino) aniline derivatives: Synthesis and spectroscopic characterization
Beck et al. Hydroamination of 1, 1-dimethylallene with primary aryl amines under mild conditions: An atom-economical route to N-(1, 1-dimethyl-2-propenyl)-anilines
Zimmermann et al. Mono‐and Bidentate Phosphine Ligands in the Palladium‐Catalyzed Methyl Acrylate Dimerization
CN110156832A (zh) 双缩醛基苯基膦、它们的制备方法及在偶联反应中的用途
HK1186733B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EP3794004B1 (en) Molecular catalysts for selective hydrogenolysis of amides
NZ603483B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
GB2332198A (en) Chiral aminophosphines
RS53470B (sr) Novi postupak za sintezu ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
Tam et al. Rhodium-Catalyzed Ring-Opening Reactions of Azabicyclic Alkenes with Indole Nucleophiles
WO2008134326A1 (en) Novel aldehyde composition

Legal Events

Date Code Title Description
FG Grant or registration